The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

According to a phase 1 trial, the experimental HIVconsvX vaccine is safe and immunogenic among sub-Saharan African ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...

Immuno Cure Biotech Ltd. is collaborating with Pharmajet Inc. to evaluate the safety and immunogenicity of its HIV ...